Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of "Reduce" from Brokerages

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been given a consensus recommendation of "Reduce" by the five research firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $16.50.

Several equities analysts have issued reports on OSCR shares. Wall Street Zen cut shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday. Piper Sandler reduced their price target on shares of Oscar Health from $25.00 to $18.00 and set an "overweight" rating for the company in a report on Monday. Finally, Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 24.39% of the stock is owned by company insiders.

Institutional Trading of Oscar Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp grew its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in shares of Oscar Health in the first quarter worth about $30,000. Larson Financial Group LLC lifted its position in Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after purchasing an additional 2,512 shares during the last quarter. CWM LLC raised its holdings in Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in shares of Oscar Health by 484.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock worth $45,000 after purchasing an additional 2,854 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of NYSE OSCR traded down $0.55 during trading hours on Wednesday, hitting $14.14. 14,019,768 shares of the stock were exchanged, compared to its average volume of 4,726,625. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.79. The company's fifty day simple moving average is $13.93 and its two-hundred day simple moving average is $14.52. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $3.60 billion, a PE ratio of -706.65 and a beta of 1.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm's revenue was up 42.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.62 EPS. On average, sell-side analysts predict that Oscar Health will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.